Photoshop fakes pathology
Korean researchers tested the ability of radiologists to spot CT images altered with commercially available software to introduce pathology and found that their skill is no more certain than the toss of a coin.
Korean researchers tested the ability of radiologists to spot CT images altered with commercially available software to introduce pathology and found that their skill is no more certain than the toss of a coin. Researchers from the Catholic University of Korea designed a test to find out how well 17 attending radiologists and 13 residents could spot faked and real pathology in a set of 10 images.
After being told that some of the images were digitally altered, the attending radiologists were able to spot the five fakes only 51.8% of the time. Residents spotted the fakes just 47.7% of the time.
“The recognition of retouched images was like coin flipping,” said Catholic University’s Hee Jae Chang, who presented the study at the 2009 RSNA meeting.
For more details about the study (abstract No. SSQ10-04), along with comments from the audience and moderators, go to Diagnostic Imaging’s RSNA 2009 conference reporter at diagnosticimaging.com. The article was posted Dec. 4.
And, so you know, the one on the left is the altered image.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
